A New York doctor said a test developed by Dutch researchers could help prevent rheumatoid arthritis.
Dr. Steven Abramson said the test could detect whether patients with temporary inflammatory arthritis will eventually develop rheumatoid arthritis, which is characterized by the body's immune system attacking itself, causing damage to joints, cartilage and bone, CBS News reported Monday.
The test seeks out the presence of a specific antibody tied to the condition and allows doctors to prevent the condition before it develops using arthritis drug methotrexate.
"The blood test can be positive in some people before they even develop classical rheumatoid arthritis," Abramson said.
Six million people in the United States suffer from inflammatory arthritis and half of that number will develop the rheumatoid version of the ailment as a result. Abramson said doctors are often reluctant to treat patients before rheumatoid symptoms appear because of the drug's side effects. However, he said, the test could allow doctors to know which patients should receive treatment before developing the illness.
Copyright 2006 by United Press International
Related stories:
Discovery of natural compounds that could slow blood vessel growth
Using computer models and live cell experiments, biomedical engineers at the Johns Hopkins University School of Medicine have discovered more than 100 human protein fragments that can slow or stop the growth of cells that make up new blood vessels.
Researchers propose minocycline as a promising drug for patients with Fragile X syndrome
A UC Riverside-led team of biomedical scientists has found that a readily available drug called minocycline, used widely to treat acne and skin infections, can be used to treat
Fragile X syndrome, the most common inherited cause of mental impairment and the most common cause of autism.
Protein complementarity may offer new insights into autoimmune diseases
The discovery of "complementary" antibodies against plasminogen in patients with blood vessel inflammation caused by anti-neutrophil cytoplasmic autoantibodies (ANCAs) may lead to new approaches to research, testing, and treatment of ANCA vasculitis and other autoimmune diseases, suggests a paper in the December
Journal of the American Society of Nephrology (
JASN).
Small protein may have big role in making more bone and less fat
A small protein may have a big role in helping you make more bone and less fat, researchers say. "The pathways are parallel, and the idea is if you can somehow disrupt the fat production pathway, you will get more bone," says Dr. Xingming Shi, bone biologist at the Medical College of Georgia Institute of Molecular Medicine and Genetics.
Get a Little Sun This Summer – It Could Help Save Your Life
As summer comes and people across America get ready to start slathering on the sunscreen, a note of caution is in order – a little sunshine is good for you.
3 sequencing companies join 1000 Genomes Project
Leaders of the 1000 Genomes Project announced today that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: 454 Life Sciences, a Roche company, Branford, Conn.; Applied Biosystems, an Applera Corp. business, Foster City, Calif.; and Illumina Inc., San Diego.
Scientists discover a direct route from the brain to the immune system
It used to be dogma that the brain was shut away from the actions of the immune system, shielded from the outside forces of nature. But that’s not how it is at all. In fact, thanks to the scientific detective work of Kevin Tracey, MD, it turns out that the brain talks directly to the immune system, sending commands that control the body’s inflammatory response to infection and autoimmune diseases. Understanding the intimate relationship is leading to a novel way to treat diseases triggered by a dangerous inflammatory response.
Gene identified for Crohn's disease in children
Pediatrics researchers have identified a gene variant that raises a child’s risk of Crohn’s disease, a chronic and painful condition attributed to inflammation of the gastrointestinal tract.